Xvivo Perfusion AB (publ)

PNK: XVIPF · Real-Time Price · USD
33.45
0.00 (0.00%)
At close: Apr 24, 2025, 10:24 AM

Company Description

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the United States, North America and South America, Europe, the Middle East, Africa, and the Asia Pacific.

The company offers XVIVO System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP.

It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP.

In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product.

The company was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Xvivo Perfusion AB (publ)
Xvivo Perfusion AB (publ) logo
Country SE
IPO Date Jul 21, 2014
Industry Medical - Devices
Sector Healthcare
Employees 193
CEO Christoffer Rosenblad

Contact Details

Address:
MAessans gata 10
Gothenburg,
SE
Website https://www.xvivoperfusion.com

Stock Details

Ticker Symbol XVIPF
Exchange PNK
Fiscal Year January - December
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number SE0004840718
Employer ID -
SIC Code n/a

Key Executives

Name Position
Christoffer Rosenblad Chief Executive Officer
Lena Hagman B.Sc. Chief Operating Officer & Deputy Chief Executive Officer
Kristoffer Nordstrom Chief Financial Officer
Andreas Wallinder M.D., Ph.D. Chief Medical Officer
Dr. Magnus Nilsson Ph.D. Senior Advisor
Jaya Tiwari Senior Vice President of Clinical & Regulatory Affairs North America
Johan Holmstrom Senior Vice President of Commercial Europe & RoW
Mark Reade Senior Vice President of North America
Ylva Vihoj Senior Vice President of Human Resources

Latest SEC Filings

No SEC filings available.